Evidence map›Paper›PMID 25427633›Full record

ArticleJournal of the International AIDS Society2014

Measuring adherence to antiretroviral therapy in children and adolescents in western Kenya.

Rachel C Vreeman, Winstone M Nyandiko, Hai Liu, Wanzhu Tu, Michael L Scanlon, James E Slaven, Samuel O Ayaya, Thomas S Inui

Abstract read
In one paragraph

Article in Journal of the International AIDS Society, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Rachel C VreemanChildren's Health Services Research, Department of Pediatrics, Indiana UniversitySchool of Medicine, Indianapolis, IN, USA; Academic Model Providing Access to Healthcare (AMPATH), Eldoret, Kenya; Regenstrief Institute, Inc., Indianapolis, IN, USA; rvreeman@iu.edu.
Winstone M NyandikoAcademic Model Providing Access to Healthcare (AMPATH), Eldoret, Kenya; Department of Child Health and Paediatrics, Moi University School of Medicine, Eldoret, Kenya.
Hai LiuDepartment of Biostatistics, Indiana University School of Medicine, Indianapolis, IN, USA.
Wanzhu TuDepartment of Biostatistics, Indiana University School of Medicine, Indianapolis, IN, USA.
Michael L ScanlonChildren's Health Services Research, Department of Pediatrics, Indiana UniversitySchool of Medicine, Indianapolis, IN, USA; Academic Model Providing Access to Healthcare (AMPATH), Eldoret, Kenya.
James E SlavenDepartment of Biostatistics, Indiana University School of Medicine, Indianapolis, IN, USA.
Samuel O AyayaAcademic Model Providing Access to Healthcare (AMPATH), Eldoret, Kenya; Department of Child Health and Paediatrics, Moi University School of Medicine, Eldoret, Kenya.
Thomas S InuiAcademic Model Providing Access to Healthcare (AMPATH), Eldoret, Kenya; Regenstrief Institute, Inc., Indianapolis, IN, USA; Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.

Funding

Quality Assurance and Quality Control Project Management: Improving Submissions and Study Conduct in the Human Subjects Research Prior Approval ProcessUL1TR002529 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI MOE, SHARON M, WIEHE, SARAH ELIZABETH · 2018 to 2022
$27.2M
Indiana Clinical and Translational Sciences InstituteUL1TR001108 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI DENNE, SCOTT C., SHEKHAR, ANANTHA · 2013 to 2017
$23.3M
Development of an Antiretroviral Therapy Adherence Measure for PediatricsK23MH087225 · NIMH · INDIANA UNIVERSITY INDIANAPOLIS · PI VREEMAN, RACHEL CHRISTINE · 2009 to 2013
$862k
NCATS NIH HHS UL1 TR001108NIMH NIH HHS 1K23MH087225
6 · The paper itself

Abstract

introductionHigh levels of adherence to antiretroviral therapy (ART) are central to HIV management. The objective of this study was to compare multiple measures of adherence and investigate factors associated with adherence among HIV-infected children in western Kenya.

methodsWe evaluated ART adherence prospectively for six months among HIV-infected children aged ≤14 years attending a large outpatient HIV clinic in Kenya. Adherence was reported using caregiver report, plasma drug concentrations and Medication Event Monitoring Systems (MEMS®). Kappa statistics were used to compare adherence estimates with MEMS®. Logistic regression analyses were performed to assess the association between child, caregiver and household characteristics with dichotomized adherence (MEMS® adherence ≥90% vs. <90%) and MEMS® treatment interruptions of ≥48 hours. Odds ratios (ORs) and 95% confidence intervals (95% CIs) were calculated.

resultsAmong 191 children, mean age at baseline was 8.2 years and 55% were female. Median adherence by MEMS® was 96.3% and improved over the course of follow-up (p<0.01), although 49.5% of children had at least one MEMS® treatment interruption of ≥48 hours. Adherence estimates were highest by caregiver report, and there was poor agreement between MEMS® and other adherence measures (Kappa statistics 0.04-0.37). In multivariable logistic regression, only caregiver-reported missed doses in the past 30 days (OR 1.25, 95% CI 1.14-1.39), late doses in the past seven days (OR 1.14, 95% CI 1.05-1.22) and caregiver-reported problems with getting the child to take ART (OR 1.10, 95% CI 1.01-1.20) were significantly associated with dichotomized MEMS® adherence. The caregivers reporting that ART made the child sick (OR 1.12, 95% CI 1.01-1.25) and reporting difficulties in the community that made giving ART more difficult (e.g. stigma) (OR 1.14, 95% CI 1.02-1.27) were significantly associated with MEMS® treatment interruptions in multivariable logistic regression.

conclusionsNon-adherence in the form of missed and late doses, treatment interruptions of more than 48 hours and sub-therapeutic drug levels were common in this cohort. Adherence varied significantly by adherence measure, suggesting that additional validation of adherence measures is needed. Few factors were consistently associated with non-adherence or treatment interruptions.

Indexed as

Medication AdherenceAdolescentAnti-Retroviral AgentsAntiretroviral Therapy, Highly ActiveChildChild, PreschoolCohort StudiesFemaleHIV InfectionsHumansKenyaMaleProspective StudiesAnti-Retroviral Agentsadherencebest practicepaediatric HIVresource-limited setting

Identifiers

PMID25427633
PMCPMC4245448

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.